Financial Advocates Investment Management Tg Therapeutics, Inc. Transaction History

Financial Advocates Investment Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 04, 2021	SELL	$21.78 - $40.45 $118,112 - $219,360	-5,423 Closed	0 $0
Q2 2021 Aug 03, 2021	SELL	$32.5 - $48.96 $292 - $440	-9 Reduced 0.17%	5,423 $210,000
Q4 2020 Feb 12, 2021	SELL	$25.27 - $54.9 $57,312 - $124,513	-2,268 Reduced 29.45%	5,432 $283,000
Q4 2018 Feb 14, 2019	BUY	$3.44 - $5.76 $8,600 - $14,400	2,500 Added 48.08%	7,700 $31,000
Q3 2018 Nov 14, 2018	BUY	$5.15 - $14.0 $26,780 - $72,800	5,200 New	5,200 $0

338

87.7M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.68B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Financial Advocates Investment Management, based on Form 13F filings with the SEC.

Stay updated on Financial Advocates Investment Management with notifications on news.